Drew Moghanaki, Professor, Chief of Thoracic Oncology at David Geffen School of Medicine at UCLA, shared on LinkedIn:
“I recently learned about ‘Synthetic PET’ from colleagues at MD Anderson; it uses radiogenomics to enhance CT images can improve
- cancer diagnosis
- risk prediction
- prognosis.
I hope it can someday reduce the overuse of PET scans, which, to me, is a Cold War era leftover that never fulfilled its promise to improve clinical outcomes.”
Read the full article:
Article: Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept
Authors: Morteza Salehjahromi, Tatiana V. Karpinets, Sheeba J. Sujit, Mohamed Qayati, Pingjun Chen, Muhammad Aminu, Maliazurina B. Saad, Rukhmini Bandyopadhyay, Lingzhi Hong, Ajay Sheshadri, Julie Qiaojin Lin, Mara B. Antonoff, Boris Sepesi, Edwin J. Ostrin, Iakovos Toumazis, Peng Huang, Chao Cheng, Tina Cascone, Natalie I. Vokes, Carmen Behrens, Jeffrey H. Siewerdsen, John D. Hazle, Joe Y. Chang, Jianhua Zhang, Yang Lü, Myrna C. B. Godoy, Caroline Chung, David A. Jaffray, Ignacio I. Wistuba, J. Jack Lee, Ara A. Vaporciyan, Don L. Gibbons, Gregory W. Gladish, John V. Heymach, Carol C. Wu, Jianjun Zhang, Jia Wu
You may also be interested in:
Low-Dose CT Screening and the Challenge of Implementation – Lung Cancer Europe
